SBIO Increases on Biotech’s Sustained Rebound

A surge in biotech stocks that began in mid-June is lasting longer than skeptics expected, with no signs of slowing down. The ALPS Medical Breakthroughs ETF (SBIO) gained 7.74% in June as positive drug trial data and M&A activity in the biotech space outweighed investors’ broad market recession fears. The fund has increased 28.95% since [...] The post SBIO Increases on Biotech’s Sustained Rebound appeared first on ETF Trends .
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.